DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Drotaverine is an investigational drug.
There have been 6 clinical trials for Drotaverine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.
The most common disease conditions in clinical trials are Asphyxia Neonatorum, Asphyxia, and Dilatation, Pathologic. The leading clinical trial sponsors are Changhai Hospital, Ain Shams University, and Ain Shams Maternity Hospital.
There are one hundred and eighty-eight US patents protecting this investigational drug and two international patents.
Recent Clinical Trials for Drotaverine
|Morphine Versus Ketorolac in Renal Colic||Loredana Ghinea||Phase 4|
|The Impact of Papaverine on First Stage of Labor||eran ashwal||Phase 3|
|Drotaverine to Shorten the Length of Labor||Ain Shams Maternity Hospital||Phase 2/Phase 3|
Top disease conditions for Drotaverine
Top clinical trial sponsors for Drotaverine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Drotaverine||⤷ Try it Free||Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells||Selecta Biosciences, Inc. (Watertown, MA)||⤷ Try it Free|
|Drotaverine||⤷ Try it Free||Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses||Selecta Biosciences, Inc. (Watertown, MA)||⤷ Try it Free|
|Drotaverine||⤷ Try it Free||Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses||Selecta Biosciences, Inc. (Watertown, MA)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Drotaverine||Australia||AU2011279250||2030-07-12||⤷ Try it Free|
|Drotaverine||Australia||AU2012249401||2030-07-12||⤷ Try it Free|
|Drotaverine||Australia||AU2012249419||2030-07-12||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|